2026 has been a concentrated year for peptide therapeutics. Efficacy reached a new high in late-stage trials, the obesity field moved beyond the incretins to amylin, the oral route reached weight management, and peptide-guided radioligand therapy kept advancing — each point tied to a specific 2025–2026 result.

Harmful

Health Hazard

Danger

H317May cause an allergic skin reaction

H332Harmful if inhaled

H334May cause allergy or asthma symptoms or breathing difficulties if inhaled

H360May damage fertility or the unborn child

H361Suspected of damaging fertility or the unborn child

H372Causes damage to organs through prolonged or repeated exposure

Customs Tariff Classification

The international HS code for DELTA-(L-ALPHA-AMINOADIPOYL)-L-CYSTEINYL-GLYCINE (CAS 9002-61-3) is 2937.19.

HS code (international, 6-digit)

2937.19

EU CN code (8-digit)

2937 19 00

Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.

Identifiers

IUPAC Name

(2S)-2-amino-6-[[(2R)-1-(carboxymethylamino)-1-oxo-3-sulfanylpropan-2-yl]amino]-6-oxohexanoic acid

InChIKey

XFOOPZIJVVDYHI-BQBZGAKWSA-N

SMILES

C(C[C@@H](C(=O)O)N)CC(=O)N[C@@H](CS)C(=O)NCC(=O)O

Synonyms (5)

HCG
Chorionic gonadotrophin

Sourcing DELTA-(L-ALPHA-AMINOADIPOYL)-L-CYSTEINYL-GLYCINE?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request Supplier? List your product for this CAS

DELTA-(L-ALPHA-AMINOADIPOYL)-L-CYSTEINYL-GLYCINE

Related Compounds

Related Reading

Safety Reference

Customs Tariff Classification